{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:54:31Z","timestamp":1772819671132,"version":"3.50.1"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA041750"],"award-info":[{"award-number":["DA041750"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH100930"],"award-info":[{"award-number":["MH100930"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To generate new mechanistic hypotheses on the pathogenesis and disease progression of neuroHIV and identify novel therapeutic targets to improve neuropsychological function in people with HIV, we investigated host genes and pathway dysregulations associated with brain HIV RNA load in gene expression profiles of the frontal cortex, basal ganglia, and white matter of HIV+ patients. Pathway analyses showed that host genes correlated with HIV expression in all three brain regions were predominantly related to inflammation, neurodegeneration, and bioenergetics. HIV RNA load directly correlated particularly with inflammation genesets representative of cytokine signaling, and this was more prominent in white matter and the basal ganglia. Increases in interferon signaling were correlated with high brain HIV RNA load in the basal ganglia and the white matter although not in the frontal cortex. Brain HIV RNA load was inversely correlated with genesets that are indicative of neuronal and synaptic genes, particularly in the cortex, indicative of synaptic injury and neurodegeneration. Brain HIV RNA load was inversely correlated with genesets that are representative of oxidative phosphorylation, electron transfer, and the tricarboxylic acid cycle in all three brain regions. Mitochondrial dysfunction has been implicated in the toxicity of some antiretrovirals, and these results indicate that mitochondrial dysfunction is also associated with productive HIV infection. Genes and pathways correlated with brain HIV RNA load suggest potential therapeutic targets to ameliorate neuropsychological functioning in people living with HIV.<\/jats:p>","DOI":"10.1038\/s41598-021-88052-7","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T10:16:45Z","timestamp":1623233805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Central nervous system (CNS) transcriptomic correlates of human immunodeficiency virus (HIV) brain RNA load in HIV-infected individuals"],"prefix":"10.1038","volume":"11","author":[{"given":"Pietro Paolo","family":"Sanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celine","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vez","family":"Repunte-Canonigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"key":"88052_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","volume":"17","author":"RK Heaton","year":"2011","unstructured":"Heaton, R. K. et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J. Neurovirol. 17, 3\u201316. https:\/\/doi.org\/10.1007\/s13365-010-0006-1 (2011).","journal-title":"J. Neurovirol."},{"key":"88052_CR2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/13550280490521078","volume":"10","author":"LA Cysique","year":"2004","unstructured":"Cysique, L. A., Maruff, P. & Brew, B. J. Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected\/acquired immunodeficiency syndrome (HIV\/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J. Neurovirol. 10, 350\u2013357 (2004).","journal-title":"J. Neurovirol."},{"key":"88052_CR3","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1089\/aid.2005.21.706","volume":"21","author":"V Tozzi","year":"2005","unstructured":"Tozzi, V. et al. Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. AIDS Res. Hum. Retroviruses 21, 706\u2013713 (2005).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"88052_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/00126334-200210010-00007","volume":"31","author":"JK Neuenburg","year":"2002","unstructured":"Neuenburg, J. K. et al. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 31, 171\u2013177 (2002).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"88052_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jneuroim.2004.08.042","volume":"157","author":"JC McArthur","year":"2004","unstructured":"McArthur, J. C. HIV dementia: an evolving disease. J. Neuroimmunol. 157, 3\u201310 (2004).","journal-title":"J. Neuroimmunol."},{"issue":"Suppl 1","key":"88052_CR6","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1097\/00002030-200418001-00011","volume":"18","author":"BJ Brew","year":"2004","unstructured":"Brew, B. J. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 18(Suppl 1), S75-78 (2004).","journal-title":"AIDS"},{"key":"88052_CR7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/13550280903131915","volume":"15","author":"I Everall","year":"2009","unstructured":"Everall, I. et al. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J. Neurovirol. 15, 360\u2013370. https:\/\/doi.org\/10.1080\/13550280903131915 (2009).","journal-title":"J. Neurovirol."},{"key":"88052_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/COH.0000000000000102","volume":"9","author":"N Sacktor","year":"2014","unstructured":"Sacktor, N. & Robertson, K. Evolving clinical phenotypes in HIV-associated neurocognitive disorders. Curr. Opin. HIV AIDS 9, 517\u2013520. https:\/\/doi.org\/10.1097\/COH.0000000000000102 (2014).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"88052_CR9","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","volume":"69","author":"A Antinori","year":"2007","unstructured":"Antinori, A. et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69, 1789\u20131799. https:\/\/doi.org\/10.1212\/01.WNL.0000287431.88658.8b (2007).","journal-title":"Neurology"},{"key":"88052_CR10","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/QAI.0b013e31827f1bdb","volume":"62","author":"BB Gelman","year":"2013","unstructured":"Gelman, B. B. et al. Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. J. Acquir. Immune Defic. Syndr. 62, 487\u2013495. https:\/\/doi.org\/10.1097\/QAI.0b013e31827f1bdb (2013).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"88052_CR11","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1128\/JVI.00674-16","volume":"90","author":"SL Lamers","year":"2016","unstructured":"Lamers, S. L. et al. HIV DNA is frequently present within pathologic tissues evaluated at autopsy from combined antiretroviral therapy-treated patients with undetectable viral loads. J. Virol. 90, 8968\u20138983. https:\/\/doi.org\/10.1128\/JVI.00674-16 (2016).","journal-title":"J. Virol."},{"key":"88052_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s13365-017-0601-5","volume":"24","author":"BB Gelman","year":"2018","unstructured":"Gelman, B. B., Endsley, J. & Kolson, D. When do models of NeuroAIDS faithfully imitate \u201cthe real thing\u201d?. J. Neurovirol. 24, 146\u2013155. https:\/\/doi.org\/10.1007\/s13365-017-0601-5 (2018).","journal-title":"J. Neurovirol."},{"key":"88052_CR13","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/COH.0000000000000108","volume":"9","author":"LR Gray","year":"2014","unstructured":"Gray, L. R. et al. Is the central nervous system a reservoir of HIV-1?. Curr. Opin. HIV AIDS 9, 552\u2013558. https:\/\/doi.org\/10.1097\/COH.0000000000000108 (2014).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"88052_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11481-018-9809-2","volume":"14","author":"A Ko","year":"2019","unstructured":"Ko, A. et al. Macrophages but not astrocytes harbor HIV DNA in the brains of HIV-1-infected aviremic individuals on suppressive antiretroviral therapy. J. Neuroimmune Pharmacol. 14, 110\u2013119. https:\/\/doi.org\/10.1007\/s11481-018-9809-2 (2019).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"88052_CR15","doi-asserted-by":"publisher","first-page":"e0201325","DOI":"10.1371\/journal.pone.0201325","volume":"13","author":"FY Tso","year":"2018","unstructured":"Tso, F. Y. et al. Brain is a potential sanctuary for subtype C HIV-1 irrespective of ART treatment outcome. PLoS ONE 13, e0201325. https:\/\/doi.org\/10.1371\/journal.pone.0201325 (2018).","journal-title":"PLoS ONE"},{"key":"88052_CR16","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1086\/650538","volume":"50","author":"A Canestri","year":"2010","unstructured":"Canestri, A. et al. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin. Infect. Dis. 50, 773\u2013778. https:\/\/doi.org\/10.1086\/650538 (2010).","journal-title":"Clin. Infect. Dis."},{"key":"88052_CR17","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1097\/QAD.0b013e328355e6b2","volume":"26","author":"MJ Peluso","year":"2012","unstructured":"Peluso, M. J. et al. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. AIDS 26, 1765\u20131774. https:\/\/doi.org\/10.1097\/QAD.0b013e328355e6b2 (2012).","journal-title":"AIDS"},{"key":"88052_CR18","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1258\/ijsa.2011.010507","volume":"22","author":"R Bingham","year":"2011","unstructured":"Bingham, R. et al. HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape. Int. J. STD AIDS 22, 608\u2013609. https:\/\/doi.org\/10.1258\/ijsa.2011.010507 (2011).","journal-title":"Int. J. STD AIDS"},{"key":"88052_CR19","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1093\/infdis\/jiw454","volume":"214","author":"A Eden","year":"2016","unstructured":"Eden, A. et al. asymptomatic cerebrospinal fluid HIV-1 viral blips and viral escape during antiretroviral therapy: a longitudinal study. J. Infect. Dis. 214, 1822\u20131825. https:\/\/doi.org\/10.1093\/infdis\/jiw454 (2016).","journal-title":"J. Infect. Dis."},{"key":"88052_CR20","doi-asserted-by":"publisher","first-page":"e0196949","DOI":"10.1371\/journal.pone.0196949","volume":"13","author":"RG Gonzalez","year":"2018","unstructured":"Gonzalez, R. G. et al. Temporal\/compartmental changes in viral RNA and neuronal injury in a primate model of NeuroAIDS. PLoS ONE 13, e0196949. https:\/\/doi.org\/10.1371\/journal.pone.0196949 (2018).","journal-title":"PLoS ONE"},{"key":"88052_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/QAD.0000000000000553","volume":"29","author":"AK Bryant","year":"2015","unstructured":"Bryant, A. K. et al. Antiretroviral therapy reduces neurodegeneration in HIV infection. AIDS 29, 323\u2013330. https:\/\/doi.org\/10.1097\/QAD.0000000000000553 (2015).","journal-title":"AIDS"},{"key":"88052_CR22","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1093\/cid\/ciy267","volume":"67","author":"SS Mukerji","year":"2018","unstructured":"Mukerji, S. S. et al. Impact of antiretroviral regimens on cerebrospinal fluid viral escape in a prospective multicohort study of antiretroviral therapy-experienced human immunodeficiency virus-1-infected adults in the United States. Clin. Infect. Dis.. 67, 1182\u20131190. https:\/\/doi.org\/10.1093\/cid\/ciy267 (2018).","journal-title":"Clin. Infect. Dis.."},{"key":"88052_CR23","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1007\/s13365-016-0448-1","volume":"22","author":"S Nightingale","year":"2016","unstructured":"Nightingale, S. et al. Discordant CSF\/plasma HIV-1 RNA in patients with unexplained low-level viraemia. J. Neurovirol. 22, 852\u2013860. https:\/\/doi.org\/10.1007\/s13365-016-0448-1 (2016).","journal-title":"J. Neurovirol."},{"key":"88052_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/QAI.0000000000001362","volume":"75","author":"SS Mukerji","year":"2017","unstructured":"Mukerji, S. S. et al. Temporal patterns and drug resistance in CSF viral escape among ART-experienced HIV-1 infected adults. J. Acquir. Immune Defic. Syndr. 75, 246\u2013255. https:\/\/doi.org\/10.1097\/QAI.0000000000001362 (2017).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"88052_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11904-014-0240-x","volume":"12","author":"A Ciuffi","year":"2015","unstructured":"Ciuffi, A., Mohammadi, P., Golumbeanu, M., di Iulio, J. & Telenti, A. Bioinformatics and HIV latency. Curr. HIV\/AIDS Rep. 12, 97\u2013106. https:\/\/doi.org\/10.1007\/s11904-014-0240-x (2015).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"88052_CR26","doi-asserted-by":"publisher","first-page":"e0175316","DOI":"10.1371\/journal.pone.0175316","volume":"12","author":"PP Sanna","year":"2017","unstructured":"Sanna, P. P., Repunte-Canonigo, V., Masliah, E. & Lefebvre, C. Gene expression patterns associated with neurological disease in human HIV infection. PLoS ONE 12, e0175316. https:\/\/doi.org\/10.1371\/journal.pone.0175316 (2017).","journal-title":"PLoS ONE"},{"key":"88052_CR27","doi-asserted-by":"publisher","first-page":"e1004156","DOI":"10.1371\/journal.ppat.1004156","volume":"10","author":"P Mohammadi","year":"2014","unstructured":"Mohammadi, P. et al. Dynamics of HIV latency and reactivation in a primary CD4+ T cell model. PLoS Pathog. 10, e1004156. https:\/\/doi.org\/10.1371\/journal.ppat.1004156 (2014).","journal-title":"PLoS Pathog."},{"key":"88052_CR28","doi-asserted-by":"publisher","first-page":"e46178","DOI":"10.1371\/journal.pone.0046178","volume":"7","author":"BB Gelman","year":"2012","unstructured":"Gelman, B. B. et al. The national neuro AIDS tissue consortium brain gene array: two types of HIV-associated neurocognitive impairment. PLoS ONE 7, e46178. https:\/\/doi.org\/10.1371\/journal.pone.0046178 (2012).","journal-title":"PLoS ONE"},{"key":"88052_CR29","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/QAI.0000000000000800","volume":"70","author":"U Siangphoe","year":"2015","unstructured":"Siangphoe, U. & Archer, K. J. Gene expression in HIV-associated neurocognitive disorders: a meta-analysis. J. Acquir. Immune Defic. Syndr. 70, 479\u2013488. https:\/\/doi.org\/10.1097\/QAI.0000000000000800 (2015).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"88052_CR30","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s11481-012-9409-5","volume":"7","author":"A Borjabad","year":"2012","unstructured":"Borjabad, A. & Volsky, D. J. Common transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer\u2019s disease, and multiple sclerosis. J. Neuroimmune Pharmacol. 7, 914\u2013926. https:\/\/doi.org\/10.1007\/s11481-012-9409-5 (2012).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"88052_CR31","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"88052_CR32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004 (2015).","journal-title":"Cell Syst."},{"key":"88052_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"88052_CR34","doi-asserted-by":"publisher","first-page":"i282","DOI":"10.1093\/bioinformatics\/btm201","volume":"23","author":"WK Lim","year":"2007","unstructured":"Lim, W. K., Wang, K., Lefebvre, C. & Califano, A. Comparative analysis of microarray normalization procedures: effects on reverse engineering gene networks. Bioinformatics 23, i282-288. https:\/\/doi.org\/10.1093\/bioinformatics\/btm201 (2007).","journal-title":"Bioinformatics"},{"key":"88052_CR35","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740. https:\/\/doi.org\/10.1093\/bioinformatics\/btr260 (2011).","journal-title":"Bioinformatics"},{"key":"88052_CR36","doi-asserted-by":"publisher","first-page":"146502","DOI":"10.1016\/j.brainres.2019.146502","volume":"1726","author":"G de Guglielmo","year":"2020","unstructured":"de Guglielmo, G. et al. Increases in compulsivity, inflammation, and neural injury in HIV transgenic rats with escalated methamphetamine self-administration under extended-access conditions. Brain Res. 1726, 146502. https:\/\/doi.org\/10.1016\/j.brainres.2019.146502 (2020).","journal-title":"Brain Res."},{"key":"88052_CR37","doi-asserted-by":"publisher","first-page":"9271","DOI":"10.1073\/pnas.161290298","volume":"98","author":"W Reid","year":"2001","unstructured":"Reid, W. et al. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc. Natl. Acad. Sci. U.S.A. 98, 9271\u20139276 (2001).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"88052_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1750-1326-9-26","volume":"9","author":"V Repunte-Canonigo","year":"2014","unstructured":"Repunte-Canonigo, V. et al. Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats. Mol. Neurodegener. 9, 26. https:\/\/doi.org\/10.1186\/1750-1326-9-26 (2014).","journal-title":"Mol. Neurodegener."},{"key":"88052_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jneuroim.2012.03.015","volume":"247","author":"W Royal 3rd","year":"2012","unstructured":"Royal, W. 3rd. et al. Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat. J. Neuroimmunol. 247, 16\u201324. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.03.015 (2012).","journal-title":"J. Neuroimmunol."},{"key":"88052_CR40","doi-asserted-by":"publisher","first-page":"146397","DOI":"10.1016\/j.brainres.2019.146397","volume":"1724","author":"BK Jensen","year":"2019","unstructured":"Jensen, B. K., Roth, L. M., Grinspan, J. B. & Jordan-Sciutto, K. L. White matter loss and oligodendrocyte dysfunction in HIV: A consequence of the infection, the antiretroviral therapy or both?. Brain Res. 1724, 146397. https:\/\/doi.org\/10.1016\/j.brainres.2019.146397 (2019).","journal-title":"Brain Res."},{"key":"88052_CR41","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s13365-020-00874-9","volume":"26","author":"I De Benedetto","year":"2020","unstructured":"De Benedetto, I., Trunfio, M., Guastamacchia, G., Bonora, S. & Calcagno, A. A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugs. J. Neurovirol. 26, 642\u2013651. https:\/\/doi.org\/10.1007\/s13365-020-00874-9 (2020).","journal-title":"J. Neurovirol."},{"key":"88052_CR42","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s40264-016-0440-y","volume":"39","author":"GJ Treisman","year":"2016","unstructured":"Treisman, G. J. & Soudry, O. Neuropsychiatric effects of HIV antiviral medications. Drug Saf. 39, 945\u2013957. https:\/\/doi.org\/10.1007\/s40264-016-0440-y (2016).","journal-title":"Drug Saf."},{"key":"88052_CR43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/ana.410420503","volume":"42","author":"RJ Ellis","year":"1997","unstructured":"Ellis, R. J. et al. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann. Neurol. 42, 679\u2013688. https:\/\/doi.org\/10.1002\/ana.410420503 (1997).","journal-title":"Ann. Neurol."},{"key":"88052_CR44","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3109\/13550280903131915","volume":"15","author":"I Everall","year":"2009","unstructured":"Everall, I. et al. Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J. Neurovirol. 15, 360\u2013370. https:\/\/doi.org\/10.3109\/13550280903131915 (2009).","journal-title":"J. Neurovirol."},{"key":"88052_CR45","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s13365-015-0410-7","volume":"22","author":"AJ Levine","year":"2016","unstructured":"Levine, A. J. et al. Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV. J. Neurovirol. 22, 431\u2013441. https:\/\/doi.org\/10.1007\/s13365-015-0410-7 (2016).","journal-title":"J. Neurovirol."},{"key":"88052_CR46","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1093\/bioinformatics\/btm369","volume":"23","author":"A Subramanian","year":"2007","unstructured":"Subramanian, A., Kuehn, H., Gould, J., Tamayo, P. & Mesirov, J. P. GSEA-P: a desktop application for gene set enrichment analysis. Bioinformatics 23, 3251\u20133253. https:\/\/doi.org\/10.1093\/bioinformatics\/btm369 (2007).","journal-title":"Bioinformatics"},{"key":"88052_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/QAI.0000000000000532","volume":"69","author":"AM Anderson","year":"2015","unstructured":"Anderson, A. M. et al. Plasma and cerebrospinal fluid biomarkers predict cerebral injury in HIV-infected individuals on stable combination antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 69, 29\u201335. https:\/\/doi.org\/10.1097\/QAI.0000000000000532 (2015).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"88052_CR48","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/QAI.0b013e318162754f","volume":"47","author":"E Sinclair","year":"2008","unstructured":"Sinclair, E. et al. Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection. J. Acquir. Immune Defic. Syndr. 47, 544\u2013552. https:\/\/doi.org\/10.1097\/QAI.0b013e318162754f (2008).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"88052_CR49","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1086\/508750","volume":"194","author":"S Spudich","year":"2006","unstructured":"Spudich, S., Lollo, N., Liegler, T., Deeks, S. G. & Price, R. W. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure. J. Infect. Dis. 194, 1686\u20131696. https:\/\/doi.org\/10.1086\/508750 (2006).","journal-title":"J. Infect. Dis."},{"key":"88052_CR50","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1080\/00365540410025320","volume":"36","author":"A Yilmaz","year":"2004","unstructured":"Yilmaz, A. et al. Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir\/ritonavir regimen. Scand. J. Infect. Dis. 36, 823\u2013828. https:\/\/doi.org\/10.1080\/00365540410025320 (2004).","journal-title":"Scand. J. Infect. Dis."},{"key":"88052_CR51","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1086\/657342","volume":"202","author":"A Eden","year":"2010","unstructured":"Eden, A. et al. HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment. J. Infect. Dis. 202, 1819\u20131825. https:\/\/doi.org\/10.1086\/657342 (2010).","journal-title":"J. Infect. Dis."},{"key":"88052_CR52","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/QAI.0b013e31815ace97","volume":"47","author":"A Yilmaz","year":"2008","unstructured":"Yilmaz, A. et al. Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 47, 168\u2013173. https:\/\/doi.org\/10.1097\/QAI.0b013e31815ace97 (2008).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"88052_CR53","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1097\/QAD.0000000000000400","volume":"28","author":"V Dahl","year":"2014","unstructured":"Dahl, V. et al. Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation. AIDS 28, 2251\u20132258. https:\/\/doi.org\/10.1097\/QAD.0000000000000400 (2014).","journal-title":"AIDS"},{"key":"88052_CR54","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1006\/brbi.1995.1034","volume":"9","author":"MB Rho","year":"1995","unstructured":"Rho, M. B. et al. A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia. Brain Behav. Immun. 9, 366\u2013377. https:\/\/doi.org\/10.1006\/brbi.1995.1034 (1995).","journal-title":"Brain Behav. Immun."},{"key":"88052_CR55","first-page":"51","volume":"12","author":"O Perrella","year":"2001","unstructured":"Perrella, O. et al. Transforming growth factor beta-1 and interferon-alpha in the AIDS dementia complex (ADC): possible relationship with cerebral viral load?. Eur. Cytokine Netw. 12, 51\u201355 (2001).","journal-title":"Eur. Cytokine Netw."},{"key":"88052_CR56","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3109\/13550289909045379","volume":"5","author":"A Krivine","year":"1999","unstructured":"Krivine, A. et al. Measuring HIV-1 RNA and interferon-alpha in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS Dementia complex. J. Neurovirol. 5, 500\u2013506 (1999).","journal-title":"J. Neurovirol."},{"key":"88052_CR57","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/01.aids.0000218552.69834.00","volume":"20","author":"DJ Moore","year":"2006","unstructured":"Moore, D. J. et al. Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS 20, 879\u2013887 (2006).","journal-title":"AIDS"},{"key":"88052_CR58","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11481-009-9152-8","volume":"4","author":"CL Achim","year":"2009","unstructured":"Achim, C. L. et al. Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J. Neuroimmune Pharmacol. 4, 190\u2013199. https:\/\/doi.org\/10.1007\/s11481-009-9152-8 (2009).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"88052_CR59","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00002030-200501280-00004","volume":"19","author":"HC Rempel","year":"2005","unstructured":"Rempel, H. C. & Pulliam, L. HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS 19, 127\u2013135 (2005).","journal-title":"AIDS"},{"key":"88052_CR60","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/01.aids.0000161770.06158.5c","volume":"19","author":"DA Green","year":"2005","unstructured":"Green, D. A. et al. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19, 407\u2013411 (2005).","journal-title":"AIDS"},{"key":"88052_CR61","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1097\/QAD.0b013e32835a117c","volume":"26","author":"V Soontornniyomkij","year":"2012","unstructured":"Soontornniyomkij, V. et al. Cerebral beta-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE epsilon4 carriers. AIDS 26, 2327\u20132335. https:\/\/doi.org\/10.1097\/QAD.0b013e32835a117c (2012).","journal-title":"AIDS"},{"key":"88052_CR62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/jnnp.65.1.29","volume":"65","author":"MM Esiri","year":"1998","unstructured":"Esiri, M. M., Biddolph, S. C. & Morris, C. S. Prevalence of Alzheimer plaques in AIDS. J. Neurol. Neurosurg. Psychiatry 65, 29\u201333. https:\/\/doi.org\/10.1136\/jnnp.65.1.29 (1998).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"88052_CR63","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10072-012-1250-3","volume":"34","author":"PL Pan","year":"2013","unstructured":"Pan, P. L. et al. Gray matter atrophy in Parkinson\u2019s disease with dementia: evidence from meta-analysis of voxel-based morphometry studies. Neurol. Sci. 34, 613\u2013619. https:\/\/doi.org\/10.1007\/s10072-012-1250-3 (2013).","journal-title":"Neurol. Sci."},{"key":"88052_CR64","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.nbd.2012.03.029","volume":"46","author":"J Pagonabarraga","year":"2012","unstructured":"Pagonabarraga, J. & Kulisevsky, J. Cognitive impairment and dementia in Parkinson\u2019s disease. Neurobiol. Dis. 46, 590\u2013596. https:\/\/doi.org\/10.1016\/j.nbd.2012.03.029 (2012).","journal-title":"Neurobiol. Dis."},{"key":"88052_CR65","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1755-5949.2008.00064.x","volume":"15","author":"S Jesse","year":"2009","unstructured":"Jesse, S. et al. Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review. CNS Neurosci. Ther. 15, 157\u2013182. https:\/\/doi.org\/10.1111\/j.1755-5949.2008.00064.x (2009).","journal-title":"CNS Neurosci. Ther."},{"key":"88052_CR66","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.arr.2015.08.006","volume":"24","author":"D Tromp","year":"2015","unstructured":"Tromp, D., Dufour, A., Lithfous, S., Pebayle, T. & Despres, O. Episodic memory in normal aging and Alzheimer disease: Insights from imaging and behavioral studies. Ageing Res. Rev. 24, 232\u2013262. https:\/\/doi.org\/10.1016\/j.arr.2015.08.006 (2015).","journal-title":"Ageing Res. Rev."},{"key":"88052_CR67","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2174\/1567205013666160603010203","volume":"14","author":"GS Alves","year":"2017","unstructured":"Alves, G. S. et al. Neuroimaging findings related to behavioral disturbances in Alzheimer\u2019s disease: a systematic review. Curr. Alzheimer Res. 14, 61\u201375. https:\/\/doi.org\/10.2174\/1567205013666160603010203 (2017).","journal-title":"Curr. Alzheimer Res."},{"key":"88052_CR68","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1001\/archneur.65.9.1202","volume":"65","author":"AM Brickman","year":"2008","unstructured":"Brickman, A. M. et al. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch. Neurol. 65, 1202\u20131208. https:\/\/doi.org\/10.1001\/archneur.65.9.1202 (2008).","journal-title":"Arch. Neurol."},{"key":"88052_CR69","doi-asserted-by":"publisher","first-page":"c3666","DOI":"10.1136\/bmj.c3666","volume":"341","author":"S Debette","year":"2010","unstructured":"Debette, S. & Markus, H. S. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 341, c3666. https:\/\/doi.org\/10.1136\/bmj.c3666 (2010).","journal-title":"BMJ"},{"key":"88052_CR70","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.parkreldis.2013.03.008","volume":"19","author":"N Kandiah","year":"2013","unstructured":"Kandiah, N. et al. Cerebral white matter hyperintensity in Parkinson\u2019s disease: a major risk factor for mild cognitive impairment. Parkinsonism Relat. Disord. 19, 680\u2013683. https:\/\/doi.org\/10.1016\/j.parkreldis.2013.03.008 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"88052_CR71","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/jamaneurol.2013.1321","volume":"70","author":"FA Provenzano","year":"2013","unstructured":"Provenzano, F. A. et al. White matter hyperintensities and cerebral amyloidosis: necessary and sufficient for clinical expression of Alzheimer disease?. JAMA Neurol. 70, 455\u2013461. https:\/\/doi.org\/10.1001\/jamaneurol.2013.1321 (2013).","journal-title":"JAMA Neurol."},{"key":"88052_CR72","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s11481-008-9136-0","volume":"4","author":"J Xu","year":"2009","unstructured":"Xu, J. & Ikezu, T. The comorbidity of HIV-associated neurocognitive disorders and Alzheimer\u2019s disease: a foreseeable medical challenge in post-HAART era. J. Neuroimmune Pharmacol. 4, 200\u2013212. https:\/\/doi.org\/10.1007\/s11481-008-9136-0 (2009).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"88052_CR73","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181c5b445","volume":"73","author":"DB Clifford","year":"2009","unstructured":"Clifford, D. B. et al. CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology 73, 1982\u20131987. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c5b445 (2009).","journal-title":"Neurology"},{"key":"88052_CR74","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neulet.2010.03.073","volume":"475","author":"MY Aksenov","year":"2010","unstructured":"Aksenov, M. Y., Aksenova, M. V., Mactutus, C. F. & Booze, R. M. HIV-1 protein-mediated amyloidogenesis in rat hippocampal cell cultures. Neurosci. Lett. 475, 174\u2013178. https:\/\/doi.org\/10.1016\/j.neulet.2010.03.073 (2010).","journal-title":"Neurosci. Lett."},{"key":"88052_CR75","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11481-009-9151-9","volume":"4","author":"L Pulliam","year":"2009","unstructured":"Pulliam, L. HIV regulation of amyloid beta production. J. Neuroimmune Pharmacol. 4, 213\u2013217. https:\/\/doi.org\/10.1007\/s11481-009-9151-9 (2009).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"88052_CR76","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/13550280600760677","volume":"12","author":"A Daily","year":"2006","unstructured":"Daily, A., Nath, A. & Hersh, L. B. Tat peptides inhibit neprilysin. J. Neurovirol. 12, 153\u2013160. https:\/\/doi.org\/10.1080\/13550280600760677 (2006).","journal-title":"J. Neurovirol."},{"key":"88052_CR77","doi-asserted-by":"publisher","first-page":"13588","DOI":"10.1073\/pnas.1308673110","volume":"110","author":"TP Johnson","year":"2013","unstructured":"Johnson, T. P. et al. Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein. Proc. Natl. Acad. Sci. U.S.A. 110, 13588\u201313593. https:\/\/doi.org\/10.1073\/pnas.1308673110 (2013).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"88052_CR78","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nsmb.3379","volume":"24","author":"A Hategan","year":"2017","unstructured":"Hategan, A. et al. HIV Tat protein and amyloid-beta peptide form multifibrillar structures that cause neurotoxicity. Nat. Struct. Mol. Biol. 24, 379\u2013386. https:\/\/doi.org\/10.1038\/nsmb.3379 (2017).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"88052_CR79","unstructured":"Giunta, B. et al. HIV-1 Tat contributes to Alzheimer's disease-like pathology in PSAPP mice. Int J Clin Exp Pathol. 2, 433\u2013443. (2009). PMID: 19294002"},{"key":"88052_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.dadm.2016.03.009","volume":"4","author":"RS Turner","year":"2016","unstructured":"Turner, R. S. et al. An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition. Alzheimers Dement (Amst) 4, 1\u20135. https:\/\/doi.org\/10.1016\/j.dadm.2016.03.009 (2016).","journal-title":"Alzheimers Dement (Amst)"},{"key":"88052_CR81","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nm0418-376","volume":"24","author":"S Chakradhar","year":"2018","unstructured":"Chakradhar, S. A tale of two diseases: aging HIV patients inspire a closer look at Alzheimer\u2019s disease. Nat. Med. 24, 376\u2013377. https:\/\/doi.org\/10.1038\/nm0418-376 (2018).","journal-title":"Nat. Med."},{"key":"88052_CR82","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12883-015-0298-0","volume":"15","author":"LA Cysique","year":"2015","unstructured":"Cysique, L. A. et al. APOE epsilon4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals\u2014a cross-sectional observational study. BMC Neurol. 15, 51. https:\/\/doi.org\/10.1186\/s12883-015-0298-0 (2015).","journal-title":"BMC Neurol."},{"key":"88052_CR83","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11904-017-0361-0","volume":"14","author":"B Milanini","year":"2017","unstructured":"Milanini, B. & Valcour, V. Differentiating HIV-associated neurocognitive disorders from Alzheimer\u2019s disease: an emerging issue in geriatric neuroHIV. Curr. HIV\/AIDS Rep. 14, 123\u2013132. https:\/\/doi.org\/10.1007\/s11904-017-0361-0 (2017).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"88052_CR84","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1212\/WNL.0000000000009236","volume":"94","author":"RH Swerdlow","year":"2020","unstructured":"Swerdlow, R. H. Mitochondria in Alzheimer brains: a PET project shows complex changes. Neurology 94, 646\u2013647. https:\/\/doi.org\/10.1212\/WNL.0000000000009236 (2020).","journal-title":"Neurology"},{"key":"88052_CR85","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/14737175.2016.1205488","volume":"17","author":"S Cardoso","year":"2017","unstructured":"Cardoso, S., Seica, R. M. & Moreira, P. I. Mitochondria as a target for neuroprotection: implications for Alzheimer s disease. Expert Rev. Neurother. 17, 77\u201391. https:\/\/doi.org\/10.1080\/14737175.2016.1205488 (2017).","journal-title":"Expert Rev. Neurother."},{"key":"88052_CR86","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s12035-020-01926-1","volume":"57","author":"G Monzio-Compagnoni","year":"2020","unstructured":"Monzio-Compagnoni, G. et al. The role of mitochondria in neurodegenerative diseases: the lesson from Alzheimer\u2019s disease and Parkinson\u2019s disease. Mol. Neurobiol. 57, 2959\u20132980. https:\/\/doi.org\/10.1007\/s12035-020-01926-1 (2020).","journal-title":"Mol. Neurobiol."},{"key":"88052_CR87","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1087753","volume":"302","author":"TM Dawson","year":"2003","unstructured":"Dawson, T. M. & Dawson, V. L. Molecular pathways of neurodegeneration in Parkinson\u2019s disease. Science 302, 819\u2013822. https:\/\/doi.org\/10.1126\/science.1087753 (2003).","journal-title":"Science"},{"key":"88052_CR88","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/ana.410430212","volume":"43","author":"EJ Brierley","year":"1998","unstructured":"Brierley, E. J., Johnson, M. A., Lightowlers, R. N., James, O. F. & Turnbull, D. M. Role of mitochondrial DNA mutations in human aging: implications for the central nervous system and muscle. Ann. Neurol. 43, 217\u2013223. https:\/\/doi.org\/10.1002\/ana.410430212 (1998).","journal-title":"Ann. Neurol."},{"key":"88052_CR89","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/COH.0000000000000607","volume":"15","author":"M Hunt","year":"2020","unstructured":"Hunt, M. & Payne, B. A. I. Mitochondria and ageing with HIV. Curr. Opin. HIV AIDS 15, 101\u2013109. https:\/\/doi.org\/10.1097\/COH.0000000000000607 (2020).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"88052_CR90","doi-asserted-by":"publisher","first-page":"104502","DOI":"10.1016\/j.nbd.2019.104502","volume":"130","author":"MK Swinton","year":"2019","unstructured":"Swinton, M. K. et al. Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: implications for therapeutic targeting of astroglia. Neurobiol. Dis. 130, 104502. https:\/\/doi.org\/10.1016\/j.nbd.2019.104502 (2019).","journal-title":"Neurobiol. Dis."},{"key":"88052_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2012.04.001","volume":"1458","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. et al. Accumulation of nuclear and mitochondrial DNA damage in the frontal cortex cells of patients with HIV-associated neurocognitive disorders. Brain Res. 1458, 1\u201311. https:\/\/doi.org\/10.1016\/j.brainres.2012.04.001 (2012).","journal-title":"Brain Res."},{"key":"88052_CR92","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1086\/423176","volume":"39","author":"O Miro","year":"2004","unstructured":"Miro, O. et al. Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals. Clin. Infect. Dis. 39, 710\u2013716. https:\/\/doi.org\/10.1086\/423176 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"88052_CR93","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.nbd.2015.11.015","volume":"86","author":"JA Fields","year":"2016","unstructured":"Fields, J. A. et al. HIV alters neuronal mitochondrial fission\/fusion in the brain during HIV-associated neurocognitive disorders. Neurobiol. Dis. 86, 154\u2013169. https:\/\/doi.org\/10.1016\/j.nbd.2015.11.015 (2016).","journal-title":"Neurobiol. Dis."},{"key":"88052_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.00993-18","volume":"92","author":"C Teodorof-Diedrich","year":"2018","unstructured":"Teodorof-Diedrich, C. & Spector, S. A. Human immunodeficiency virus type 1 gp120 and tat induce mitochondrial fragmentation and incomplete mitophagy in human neurons. J. Virol. 92, 1. https:\/\/doi.org\/10.1128\/JVI.00993-18 (2018).","journal-title":"J. Virol."},{"key":"88052_CR95","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s12640-017-9776-z","volume":"32","author":"SJ Rozzi","year":"2017","unstructured":"Rozzi, S. J. et al. Human immunodeficiency virus promotes mitochondrial toxicity. Neurotox Res. 32, 723\u2013733. https:\/\/doi.org\/10.1007\/s12640-017-9776-z (2017).","journal-title":"Neurotox Res."},{"key":"88052_CR96","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1080\/15548627.2018.1476810","volume":"14","author":"A Thangaraj","year":"2018","unstructured":"Thangaraj, A. et al. HIV-1 TAT-mediated microglial activation: role of mitochondrial dysfunction and defective mitophagy. Autophagy 14, 1596\u20131619. https:\/\/doi.org\/10.1080\/15548627.2018.1476810 (2018).","journal-title":"Autophagy"},{"key":"88052_CR97","doi-asserted-by":"publisher","first-page":"869","DOI":"10.4049\/jimmunol.178.2.869","volume":"178","author":"JP Norman","year":"2007","unstructured":"Norman, J. P., Perry, S. W., Kasischke, K. A., Volsky, D. J. & Gelbard, H. A. HIV-1 trans activator of transcription protein elicits mitochondrial hyperpolarization and respiratory deficit, with dysregulation of complex IV and nicotinamide adenine dinucleotide homeostasis in cortical neurons. J. Immunol. 178, 869\u2013876. https:\/\/doi.org\/10.4049\/jimmunol.178.2.869 (2007).","journal-title":"J. Immunol."},{"key":"88052_CR98","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1038\/cddis.2012.21","volume":"3","author":"H Lecoeur","year":"2012","unstructured":"Lecoeur, H. et al. HIV-1 Tat protein directly induces mitochondrial membrane permeabilization and inactivates cytochrome c oxidase. Cell Death Dis. 3, e282. https:\/\/doi.org\/10.1038\/cddis.2012.21 (2012).","journal-title":"Cell Death Dis."},{"key":"88052_CR99","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41420-017-0013-6","volume":"4","author":"SJ Rozzi","year":"2018","unstructured":"Rozzi, S. J., Avdoshina, V., Fields, J. A. & Mocchetti, I. Human immunodeficiency virus Tat impairs mitochondrial fission in neurons. Cell Death Discov. 4, 8. https:\/\/doi.org\/10.1038\/s41420-017-0013-6 (2018).","journal-title":"Cell Death Discov."},{"key":"88052_CR100","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s12640-016-9608-6","volume":"29","author":"V Avdoshina","year":"2016","unstructured":"Avdoshina, V. et al. The HIV protein gp120 alters mitochondrial dynamics in neurons. Neurotox Res. 29, 583\u2013593. https:\/\/doi.org\/10.1007\/s12640-016-9608-6 (2016).","journal-title":"Neurotox Res."},{"key":"88052_CR101","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s13365-017-0573-5","volume":"23","author":"KL Stauch","year":"2017","unstructured":"Stauch, K. L., Emanuel, K., Lamberty, B. G., Morsey, B. & Fox, H. S. Central nervous system-penetrating antiretrovirals impair energetic reserve in striatal nerve terminals. J. Neurovirol. 23, 795\u2013807. https:\/\/doi.org\/10.1007\/s13365-017-0573-5 (2017).","journal-title":"J. Neurovirol."},{"key":"88052_CR102","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11904-020-00484-4","volume":"17","author":"TR Butterfield","year":"2020","unstructured":"Butterfield, T. R., Landay, A. L. & Anzinger, J. J. Dysfunctional immunometabolism in HIV Infection: Contributing Factors and Implications for Age-Related Comorbid Diseases. Curr HIV\/AIDS Rep 17, 125\u2013137. https:\/\/doi.org\/10.1007\/s11904-020-00484-4 (2020).","journal-title":"Curr HIV\/AIDS Rep"},{"key":"88052_CR103","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10863-009-9241-7","volume":"41","author":"R Sultana","year":"2009","unstructured":"Sultana, R. & Butterfield, D. A. Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment. J. Bioenergy Biomembr. 41, 441\u2013446. https:\/\/doi.org\/10.1007\/s10863-009-9241-7 (2009).","journal-title":"J. Bioenergy Biomembr."},{"key":"88052_CR104","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3389\/fphar.2019.00902","volume":"10","author":"G Cenini","year":"2019","unstructured":"Cenini, G. & Voos, W. Mitochondria as potential targets in Alzheimer disease therapy: an update. Front. Pharmacol. 10, 902. https:\/\/doi.org\/10.3389\/fphar.2019.00902 (2019).","journal-title":"Front. Pharmacol."},{"key":"88052_CR105","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/AID.2019.0240","volume":"36","author":"KJ Kallianpur","year":"2020","unstructured":"Kallianpur, K. J. et al. Systemic mitochondrial oxidative phosphorylation protein levels correlate with neuroimaging measures in chronically HIV-infected individuals. AIDS Res. Hum. Retroviruses 36, 83\u201391. https:\/\/doi.org\/10.1089\/AID.2019.0240 (2020).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"88052_CR106","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Martinez-Reyes","year":"2020","unstructured":"Martinez-Reyes, I. & Chandel, N. S. Mitochondrial TCA cycle metabolites control physiology and disease. Nat. Commun. 11, 102. https:\/\/doi.org\/10.1038\/s41467-019-13668-3 (2020).","journal-title":"Nat. Commun."},{"key":"88052_CR107","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cmet.2015.02.002","volume":"21","author":"A Moussaieff","year":"2015","unstructured":"Moussaieff, A. et al. Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells. Cell Metab. 21, 392\u2013402. https:\/\/doi.org\/10.1016\/j.cmet.2015.02.002 (2015).","journal-title":"Cell Metab."},{"key":"88052_CR108","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.cmet.2014.06.004","volume":"20","author":"JV Lee","year":"2014","unstructured":"Lee, J. V. et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab. 20, 306\u2013319. https:\/\/doi.org\/10.1016\/j.cmet.2014.06.004 (2014).","journal-title":"Cell Metab."},{"key":"88052_CR109","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1126\/science.1164097","volume":"324","author":"KE Wellen","year":"2009","unstructured":"Wellen, K. E. et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324, 1076\u20131080. https:\/\/doi.org\/10.1126\/science.1164097 (2009).","journal-title":"Science"},{"key":"88052_CR110","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41586-019-1700-7","volume":"574","author":"P Mews","year":"2019","unstructured":"Mews, P. et al. Alcohol metabolism contributes to brain histone acetylation. Nature 574, 717\u2013721. https:\/\/doi.org\/10.1038\/s41586-019-1700-7 (2019).","journal-title":"Nature"},{"key":"88052_CR111","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","volume":"14","author":"M Belanger","year":"2011","unstructured":"Belanger, M., Allaman, I. & Magistretti, P. J. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 14, 724\u2013738. https:\/\/doi.org\/10.1016\/j.cmet.2011.08.016 (2011).","journal-title":"Cell Metab."},{"key":"88052_CR112","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/QAD.0000000000000580","volume":"29","author":"AM Dickens","year":"2015","unstructured":"Dickens, A. M. et al. Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients. AIDS 29, 559\u2013569. https:\/\/doi.org\/10.1097\/QAD.0000000000000580 (2015).","journal-title":"AIDS"},{"key":"88052_CR113","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1097\/QAD.0000000000000303","volume":"28","author":"E Cassol","year":"2014","unstructured":"Cassol, E., Misra, V., Dutta, A., Morgello, S. & Gabuzda, D. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment. AIDS 28, 1579\u20131591. https:\/\/doi.org\/10.1097\/QAD.0000000000000303 (2014).","journal-title":"AIDS"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88052-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88052-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88052-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T09:23:42Z","timestamp":1670059422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88052-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88052"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88052-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,9]]},"assertion":[{"value":"17 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12176"}}